Eli Lilly and Co
lilly.comEli Lilly and Company (NYSE: LLY) is a pharmaceutical company that discovers, develops, manufactures, and sells prescription medicines. Revenue is generated through transactional sales of branded drugs to wholesalers, pharmacies, hospitals, and government payers, with pricing set at the brand level and subject to rebates and formulary negotiations. The filing excerpts provided do not contain sufficient detail to characterize segment revenue percentages, key product names, competitive position, geographic mix, leadership tenure, or founding history. Accordingly, those specifics are omitted. What the cover page of the 10-K filed February 12, 2026 (accession 0000059478-26-000013) confirms is that Lilly is a well-known seasoned issuer registered under Section 12(b) of the Securities Exchange Act, with securities listed on a national exchange under the ticker LLY, and that it files annual reports for fiscal years ended in accordance with SEC requirements.
Products & Services
Prescription pharmaceutical products. Specific drug names, therapeutic categories, and brand portfolios are not supported by the provided filing excerpts.
Revenue Model
Transactional sales of branded prescription medicines to wholesalers, pharmacies, hospitals, and government payers, with net revenue reduced by rebates and payer negotiations. Specific revenue figures are not supported by the provided filing excerpts.
Customers & Markets
Wholesalers, pharmacies, hospitals, and government payers in prescription pharmaceutical end markets. Specific customer concentration data are not supported by the provided filing excerpts.
Geographic Exposure
Not supported by the provided filing excerpts.
Financial Snapshot
Loading...
